CompletedNCT00885950
Prevention of the Hepatic Sinusoidal Obstruction Syndrome by Means of Anticoagulants
Studying Hepatic veno-occlusive disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Maastricht University Medical Center
- Principal Investigator
- Steven WM Olde Damink, MD, PhD, MScMaastricht University Medical Centre
- Enrollment
- 80 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2008 – 2010
Study locations (1)
- Department of Surgery; Maastricht University Medical Centre, Maastricht, Netherlands
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00885950 on ClinicalTrials.govOther trials for Hepatic veno-occlusive disease
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT05987124Defibrotide Dose-escalation for SOS Post-HSCTNew York Medical College
- RECRUITINGNCT06715046Cell Free DNA Profiling As a Tool to Monitor Clinically-Relevant Events in Allogeneic Hematopoietic Stem Cell TransplantationUniversity of Turin, Italy
- RECRUITINGNCT05090345A Prospective Registry of Pediatric Cellular Therapy Patients at Risk for Endothelial Dysfunction, Sinusoidal Obstruction Syndrome and/or Multi-Organ Dysfunction Syndrome (MODS).Duke University
- ACTIVE NOT RECRUITINGNANCT03865589Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction SyndromeChildren's Mercy Hospital Kansas City